GlassScriptPhysician profile
Moisey Fridman
NPI 1336187434
$982.98
in general payments reported to CMS, 2019-2025
15 companies · $277 in 2025
The $277 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $120 · 2021: $89.11 · 2022: $85.87 · 2023: $123 · 2024: $288 · 2025: $277.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $688.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $687.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $425.88 | 2019-2025 | Veozah, Myrbetriq |
| Hologic Sales and Service, LLC | $131.42 | 2021-2022 | |
| Esperion Therapeutics, INC. | $112.95 | 2024 | Nexletol |
| Sumitomo Pharma America, INC. | $72.58 | 2023-2025 | Gemtesa |
| Exact Sciences Corporation | $30.00 | 2024 | Cologuard Collection Kit |
| Amneal Pharmaceuticals LLC | $28.95 | 2024 | Unithroid |
| Xeris Pharmaceuticals, INC. | $25.00 | 2023 | Gvoke Hypopen |
| Ascendis Pharma Endocrinology INC | $23.07 | 2025 | Yorvipath |
| Scynexis, INC. | $22.48 | 2022 | |
| Tandem Diabetes Care, INC. | $21.74 | 2025 | T:Slim X2 Insulin Pump With Control-Iq |
| Amarin Pharma, INC. | $21.08 | 2022 | |
| Rhythm Pharmaceuticals, INC. | $19.08 | 2025 | Imcivree |
| Amag Pharmaceuticals, INC. | $18.53 | 2019 | |
| Therapeuticsmd, INC. | $16.93 | 2019 | |
| Mylan Pharmaceuticals INC. | $13.29 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Moisey Fridman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.